You are a writer at a medical communications agency supporting development of the first draft of a manuscript reporting primary results from a phase 3 clinical trial. At your client's request, you are using the pharmaceutical company's internally developed generative...
Clear, accessible communication is fundamental to high-quality medical communications. That’s why ISMPP is proud to support the use of the Multi-Regional Clinical Trials (MRCT) Center’s Clinical Research Glossary, a patient-centered, consensus-driven resource...
A perspective from the 2026 European Meeting of ISMPP keynote presentation by Michael Siller, MSC, a coach and consultant with expertise in corporate culture and leadership, change management, and intercultural management Introduction In medical communications, the...
Michael Nissen, Independent Medical Publications Professional, USA; Michelle Parrish, MEDiSTRAVA, an Inizio Medical Company; Jennifer Bodkin, Envision Spark, an Envision Medical Communications Agency, Envision Pharma Group, UK; Anna Santaromita, Natera, Inc., USA; Sam...
The Volunteer Drive is open for 2026-2027 Education and Meeting Program Committees The Volunteer Drive for Strategic Initiatives Committees will launch in September 2026 Visit the Volunteer Gateway to learn more about opportunities with ISMPP! Any questions? Please...
